Skip to main content

Table 4 Pattern of prevalence and antimicrobial resistance patterns of Shigella reported from 2001 to 2014 in Ethiopia

From: Prevalence and antimicrobial susceptibility patterns of Shigella among acute diarrheal outpatients in Mekelle hospital, Northern Ethiopia

Study area

Authors

Prevalence

Amp

Cot

C

NOR

CIP

CN

AMC

AMX

Gondar

Yismaw et al. [9]

7.4

79.9

73.4

52.2

8.9

7.9

Huruy et al. [10]

16.8

81.5

75.4

50.8

9.2

10.7

Tiruneh [11]

7.5

78.9

84.6

67.8

1.1

2.2

12.2

Demissie et al. [12]

4.57

94.1

58.8

17.6

0.0

41.7

Harar

Reda et al. [14]

6.7

100

5.9

29.4

0.0

100

Bahir Dar

Debas et al. [15]

14.5

9.4

0.0

25

88.2

Hawassa

Mulatu et al. [13]

7

63

0.0

9.1

0.0

27.3

100

Butajira

Mengstu et al. [29]

4.5

47.1

76.5

29.4

5.9

17.6

Jimma

Mache [7]

20.1

70.1

32.5

40.3

  

1.3

Beyene and Tasew [8]

2.3

100

100

16.7

0.0

100

Mekelle

This study

6.9

100

66.7

46.7

6.7

6.7

13.3

33.3

86.7

  1. AMP amoxicillin, C chloramphenicol, AML amoxycillin, AMC amoxycillin Clavulanic acid, SXT sulphamethoxazole trimethoprim, NOR norfloxacin, CIP ciprofloxacin, CN gentamicin